{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:42:09Z","timestamp":1794490929270,"version":"4.9.1"},"reference-count":31,"publisher":"The Pediatric Pharmacy Association","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"abstract":"<jats:sec>\n          <jats:title>OBJECTIVE<\/jats:title>\n          <jats:p>In preterm infants, the standard pharmacologic treatment for a hemodynamically significant patent ductus arteriosus (hsPDA) is either ibuprofen or indomethacin. However, these medications may be less effective after 2 weeks of age. We investigated the use of acetaminophen in hsPDA closure beyond 2 weeks of age.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>METHODS<\/jats:title>\n          <jats:p>An observational study of 11 infants, &lt;30 weeks' gestation at birth and postnatal age &gt; 2 weeks, who received acetaminophen treatment for their hsPDA. Echocardiograms (ECHOs), B-type natriuretic peptide (BNP) levels, and the fraction of inspired oxygen (FiO<jats:sub>2<\/jats:sub>) were obtained before and after treatment to analyze ductal characteristics. Renal and liver functions were monitored pretreatment and posttreatment to look for potential medication side effects.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>RESULTS<\/jats:title>\n          <jats:p>Of the 10 infants with ECHO data for before and after acetaminophen treatments, 4\/10 (40%) had a decrease in PDA size, with no infants having complete closure immediately posttreatment. Eight of 11 (73%) infants had a decreased FiO<jats:sub>2<\/jats:sub> requirement after treatment. Of the 5 infants with pretreatment and posttreatment BNP data, 2\/5 (40%) infants had a decrease in BNP level. One infant received an additional course of acetaminophen. Four infants underwent a surgical ligation. Two infants died. No medication side effects occurred with regard to hepatic and renal function.<\/jats:p>\n        <\/jats:sec>\n        <jats:sec>\n          <jats:title>CONCLUSION<\/jats:title>\n          <jats:p>Acetaminophen is a safe and effective pharmacologic treatment to reduce the significance of the hsPDA in some infants beyond 2 weeks of age, as shown by ECHO and BNP data.<\/jats:p>\n        <\/jats:sec>","DOI":"10.5863\/1551-6776-25.6.507","type":"journal-article","created":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T15:06:28Z","timestamp":1597417588000},"page":"507-513","source":"Crossref","is-referenced-by-count":3,"title":["Late Acetaminophen Therapy for Patent Ductus Arteriosus in the Preterm Neonate"],"prefix":"10.5863","volume":"25","author":[{"given":"Ronnelle","family":"King","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Colon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Stanfel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate A.","family":"Tauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","reference":[{"issue":"1","key":"i1551-6776-25-6-507-b1","series-title":"Clin Sci (Lond)","first-page":"75","article-title":"Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants","volume":"103","year":"2002","unstructured":"Puddy\n              VF\n            , AmirmansourC, WilliamsAF, SingerDR.\n          Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci (Lond). 2002;103(1):75\u201377."},{"issue":"1","key":"i1551-6776-25-6-507-b2","series-title":"J Pediatr","first-page":"79","article-title":"B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus","volume":"157","year":"2010","unstructured":"Hsu\n              JH\n            , YangSN, ChenHL, \n          et al. B-type natriuretic peptide predicts responses to indomethacin in premature neonates with patent ductus arteriosus. J Pediatr. 2010;157(1):79\u201384."},{"issue":"1","key":"i1551-6776-25-6-507-b3","series-title":"Pediatrics","first-page":"e138","article-title":"Failure of ductus arteriosus closure is associated with increased mortality in preterm infants","volume":"123","year":"2009","unstructured":"Noori\n              S\n            , McCoyM, FriedlichP, \n          et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics. 2009;123(1):e138\u2013e144."},{"issue":"9","key":"i1551-6776-25-6-507-b4","series-title":"JAMA Pediatr","first-page":"863","article-title":"Diagnosis, evaluation, and management of patent ductus arteriosus in preterm neonates","volume":"169","year":"2015","unstructured":"Jain\n              A\n            , ShahPS.\n          Diagnosis, evaluation, and management of patent ductus arteriosus in preterm neonates. JAMA Pediatr. 2015;169(9):863\u2013872."},{"key":"i1551-6776-25-6-507-b5","series-title":"J Pediatr","first-page":"105","article-title":"Changes in the diagnosis and management of patent ductus arteriosus from 2006 to 2015 in United States neonatal intensive care units","volume":"189","year":"2017","unstructured":"Bixler\n              GM\n            , PowersGC, ClarkRH, \n          et al. Changes in the diagnosis and management of patent ductus arteriosus from 2006 to 2015 in United States neonatal intensive care units. J Pediatr. 2017;189:105\u2013112."},{"issue":"1","key":"i1551-6776-25-6-507-b6","series-title":"Congenit Heart Dis.","first-page":"21","article-title":"What is a hemodynamically significant PDA in preterm infants?","volume":"14","year":"2019","unstructured":"Shepherd\n              JL\n            , NooriS.\n          What is a hemodynamically significant PDA in preterm infants?\n          Congenit Heart Dis.\n          2019;14(1):21\u201326."},{"issue":"5","key":"i1551-6776-25-6-507-b7","series-title":"Arch Dis Child Fetal Neonatal Ed","first-page":"F419","article-title":"Severity of the ductal shunt: a comparison of different markers","volume":"90","year":"2005","unstructured":"El Hajjar\n              M\n            , VaksmannG, RakzaT, \n          et al. Severity of the ductal shunt: a comparison of different markers. Arch Dis Child Fetal Neonatal Ed. 2005;90(5):F419\u2013F422."},{"issue":"9","key":"i1551-6776-25-6-507-b8","series-title":"Am J Perinatol","first-page":"745","article-title":"Effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants","volume":"30","year":"2013","unstructured":"Sivanandan\n              S\n            , BaliV, SoraishamAS, \n          et al. Effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants. Am J Perinatol. 2013;30(9):745\u2013750."},{"issue":"5","key":"i1551-6776-25-6-507-b9","series-title":"Pediatr Cardiol","first-page":"824","article-title":"Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial","volume":"35","year":"2014","unstructured":"Yadav\n              S\n            , AgarwalS, MariaA, \n          et al. Comparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trial. Pediatr Cardiol. 2014;35(5):824\u2013830."},{"issue":"8186","key":"i1551-6776-25-6-507-b10","series-title":"Lancet","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/s0140-6736(80)90023-9","article-title":"Timing of indomethacin therapy in persistent ductus","volume":"2","year":"1980","unstructured":"Firth\n              J\n            , PickeringD.\n          Timing of indomethacin therapy in persistent ductus. Lancet. 1980;2(8186):144. doi:10.1016\/s0140-6736(80)90023-9"},{"issue":"1","key":"i1551-6776-25-6-507-b11","series-title":"Clin Perinatol","first-page":"111","article-title":"Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit","volume":"39","year":"2012","unstructured":"Johnston\n              PG\n            , Gillam-KrakauerM, FullerMP, ReeseJ.\n          Evidence-based use of indomethacin and ibuprofen in the neonatal intensive care unit. Clin Perinatol. 2012;39(1):111\u2013136."},{"issue":"1","key":"i1551-6776-25-6-507-b12","series-title":"Images Paediatr Cardiol","first-page":"1","article-title":"Pharmacological closure of the patent ductus arteriosus","volume":"5","year":"2003","unstructured":"Mehta\n              S\n            , YounoszaiA, PietzJ, AchantiB.\n          Pharmacological closure of the patent ductus arteriosus. Images Paediatr Cardiol. 2003;5(1):1\u201315."},{"issue":"11","key":"i1551-6776-25-6-507-b13","series-title":"Pharmaceuticals (Basel)","first-page":"1160","article-title":"Cyclooxygenase (COX) inhibitors and the newborn kidney","volume":"5","year":"2012","unstructured":"Smith\n              FG\n            , WadeAW, LewisML, QiW.\n          Cyclooxygenase (COX) inhibitors and the newborn kidney. Pharmaceuticals (Basel). 2012;5(11):1160\u20131176."},{"issue":"10","key":"i1551-6776-25-6-507-b14","series-title":"Am J Physiol Renal Physiol","first-page":"F1286","article-title":"Effects of ibuprofen treatment on the developing preterm baboon kidney","volume":"302","year":"2012","unstructured":"Sutherland\n              MR\n            , YoderBA, McCurninD, \n          et al. Effects of ibuprofen treatment on the developing preterm baboon kidney. Am J Physiol Renal Physiol. 2012;302(10):F1286\u2013F1292."},{"issue":"4","key":"i1551-6776-25-6-507-b15","series-title":"Semin Perinatol","first-page":"253","article-title":"Changing patterns of patent ductus arteriosus surgical ligation in the United States","volume":"42","year":"2018","unstructured":"Reese\n              J\n            , ScottTA, PatrickSW.\n          Changing patterns of patent ductus arteriosus surgical ligation in the United States. Semin Perinatol. 2018;42(4):253\u2013261."},{"issue":"6","key":"i1551-6776-25-6-507-b16","series-title":"J Pediatr","first-page":"1100","article-title":"Ligation of the patent ductus arteriosus in preterm infants: understanding the physiology","volume":"162","year":"2013","unstructured":"El-Khuffash\n              AF\n            , JainA, McNamaraPJ.\n          Ligation of the patent ductus arteriosus in preterm infants: understanding the physiology. J Pediatr. 2013;162(6):1100\u20131106."},{"issue":"4","key":"i1551-6776-25-6-507-b17","series-title":"Cochrane Database Syst Rev","doi-asserted-by":"publisher","first-page":"CD010061","DOI":"10.1002\/14651858.CD010061.pub3","article-title":"Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants","volume":"4","year":"2018","unstructured":"Ohlsson\n              A\n            , ShahPS.\n          Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low birth weight infants. Cochrane Database Syst Rev. 2018;4(4):CD010061. doi:10.1002\/14651858.CD010061.pub3"},{"key":"i1551-6776-25-6-507-b18","series-title":"Biomed Res Int.","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1155\/2017\/1438038","article-title":"Paracetamol in patent ductus arteriosus treatment: efficacious and safe?","year":"2017","unstructured":"Bardanzellu\n              F\n            , NeroniP, DessiA, FanosV.\n          Paracetamol in patent ductus arteriosus treatment: efficacious and safe?\n          Biomed Res Int.\n          2017;2017. doi:10.1155\/2017\/1438038"},{"issue":"3","key":"i1551-6776-25-6-507-b19","series-title":"Inflammopharmacology","first-page":"201","article-title":"The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings","volume":"21","year":"2013","unstructured":"Graham\n              GG\n            , DaviesMJ, DayRO, \n          et al. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21(3):201\u2013232."},{"issue":"3","key":"i1551-6776-25-6-507-b20","series-title":"Arch Dis Child Fetal Neonatal Ed","first-page":"F253","article-title":"Late medical therapy of patent ductus arteriosus using intravenous paracetamol","volume":"100","year":"2015","unstructured":"El-Khuffash\n              A\n            , JamesAT, ClearyA, \n          et al. Late medical therapy of patent ductus arteriosus using intravenous paracetamol. Arch Dis Child Fetal Neonatal Ed. 2015;100(3):F253\u2013F256."},{"issue":"8","key":"i1551-6776-25-6-507-b21","series-title":"J Perinatol","first-page":"649","article-title":"Acetaminophen to avoid surgical ligation in extremely low gestational age neonates with persistent hemodynamically significant patent ductus arteriosus","volume":"36","year":"2016","unstructured":"Weisz\n              DE\n            , MartinsFF, NieldLE, \n          et al. Acetaminophen to avoid surgical ligation in extremely low gestational age neonates with persistent hemodynamically significant patent ductus arteriosus. J Perinatol. 2016;36(8):649\u2013653."},{"issue":"1","key":"i1551-6776-25-6-507-b22","series-title":"Pediatr Cardiol","first-page":"183","article-title":"Oral paracetamol for patent ductus arteriosus rescue closure","volume":"39","year":"2018","unstructured":"Pharande\n              P\n            , WatsonH, TanK, SehgalA.\n          Oral paracetamol for patent ductus arteriosus rescue closure. Pediatr Cardiol. 2018;39(1):183\u2013190."},{"issue":"5","key":"i1551-6776-25-6-507-b23","series-title":"J Thorac Cardiovasc Surg","first-page":"1937","article-title":"Late oral acetaminophen versus immediate surgical ligation in preterm infants with persistent large patent ductus arteriosus","volume":"156","year":"2018","unstructured":"Mashally\n              S\n            , NieldLE, McNamaraPJ, \n          et al. Late oral acetaminophen versus immediate surgical ligation in preterm infants with persistent large patent ductus arteriosus. J Thorac Cardiovasc Surg. 2018;156(5):1937\u20131944."},{"issue":"2","key":"i1551-6776-25-6-507-b24","series-title":"Pediatr Cardiol","first-page":"276","article-title":"Paracetamol therapy for patent ductus arteriosus in premature infants: a chance before surgical ligation","volume":"35","year":"2014","unstructured":"Ozdemir\n              OM\n            , DoganM, KucuktasciK, \n          et al. Paracetamol therapy for patent ductus arteriosus in premature infants: a chance before surgical ligation. Pediatr Cardiol. 2014;35(2):276\u2013279."},{"key":"i1551-6776-25-6-507-b25","series-title":"The Harriet Lane Handbook: A Manual for Pediatric House Officers.","year":"2018","unstructured":"Hughes\n              H\n            , KahlL, \n          eds.The Harriet Lane Handbook: A Manual for Pediatric House Officers.21st ed. Philadelphia, PA: Elsevier; 2018."},{"issue":"2","key":"i1551-6776-25-6-507-b26","series-title":"Arch Dis Child Fetal Neonatal Ed","first-page":"F127","article-title":"Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis","volume":"101","year":"2016","unstructured":"Terrin\n              G\n            , ConteF, OncelMY, \n          et al. Paracetamol for the treatment of patent ductus arteriosus in preterm neonates: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2016;101(2):F127\u2013F136."},{"issue":"4","key":"i1551-6776-25-6-507-b27","series-title":"Pediatrics","first-page":"1113","article-title":"Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less","volume":"117","year":"2006","unstructured":"Koch\n              J\n            , HensleyG, RoyL, \n          et al. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics. 2006;117(4):1113\u20131121."},{"issue":"6","key":"i1551-6776-25-6-507-b28","series-title":"Am J Perinatol","first-page":"584","article-title":"Treatment of patent ductus arteriosus with cyclooxygenase inhibitors beyond 2 weeks of age in very low birth weight infants","volume":"33","year":"2016","unstructured":"Lainwala\n              S\n            , HussainN.\n          Treatment of patent ductus arteriosus with cyclooxygenase inhibitors beyond 2 weeks of age in very low birth weight infants. Am J Perinatol. 2016;33(6):584\u2013589."},{"issue":"8","key":"i1551-6776-25-6-507-b29","series-title":"Acta Paediatr","first-page":"e352","article-title":"B-type natriuretic peptide levels normalise in preterm infants without a patent ductus arteriosus by the fifth postnatal day","volume":"105","year":"2016","unstructured":"Tauber\n              KA\n            , DoyleR, GraninaE, MunshiU.\n          B-type natriuretic peptide levels normalise in preterm infants without a patent ductus arteriosus by the fifth postnatal day. Acta Paediatr. 2016;105(8):e352\u2013e355."},{"issue":"12","key":"i1551-6776-25-6-507-b30","series-title":"J Perinatol.","first-page":"780","article-title":"How useful are B-type natriuretic peptide measurements for monitoring changes in patent ductus arteriosus shunt magnitude?","volume":"30","year":"2010","unstructured":"Chen\n              S\n            , TacyT, ClymanR.\n          How useful are B-type natriuretic peptide measurements for monitoring changes in patent ductus arteriosus shunt magnitude?\n          J Perinatol.\n          2010;30(12):780\u2013785."},{"issue":"3","key":"i1551-6776-25-6-507-b31","series-title":"Pediatr Res","first-page":"286","article-title":"B-type natriuretic peptide to predict ductus intervention in infants <28 weeks","volume":"64","year":"2008","unstructured":"Czernik\n              C\n            , LemmerJ, MetzeB, \n          et al. B-type natriuretic peptide to predict ductus intervention in infants <28 weeks. Pediatr Res. 2008;64(3):286\u2013290."}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"link":[{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/25\/6\/article-p507.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/jppt\/article-pdf\/25\/6\/507\/2585577\/1551-6776-25_6_507.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/25\/6\/article-p507.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/jppt.kglmeridian.com\/downloadpdf\/journals\/jppt\/25\/6\/article-p507.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:39:24Z","timestamp":1747355964000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/25\/6\/article-p507.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":31,"journal-issue":{"issue":"6"},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-25.6.507","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.5863\/1551-6776-25.6.507.s","asserted-by":"subject"}]},"ISSN":["1551-6776"],"issn-type":[{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}